Is the human carcinogen arsenic carcinogenic to laboratory animals?

Toxicological Sciences

Volumn 55, Issue 1, 2000, Pages 17-23

  Huff, James ^a   Chan, Po ^a   Nyska, Abraham ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; CARCINOGEN;

CANCER RISK; CHEMICAL CARCINOGENESIS; DNA DAMAGE; EXPERIMENTAL ANIMAL; GENOTOXICITY; HUMAN; LONG TERM EXPOSURE; NONHUMAN; REVIEW;

EID: 0034024905     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/55.1.17     Document Type: Review

References (54)

1. Abernathy, C. O., Liu, Y. P., Longfellow, D., Aposhian, H. V., Beck, B., Fowler, B., Goyer, R., Menzer, R., Rossman, T., Thompson, C., and Waalkes, M. (1999). Arsenic: Health effects, mechanisms of actions, and research issues. Environ. Health Perspect. 107, 593-597.
2. Arnold, L. L., Cano, M., St. John, M., Eldan, M., van Gemert, M., and Cohen, S. M. (1999). Effects of dietary dimethylarsinic acid on the urine and urothelium of rats. Carcinogenesis 20, 2171-2179.
3. ATSDR (1999). Toxicological profile for arsenic (update). Agency for Toxic Substances and Disease Registry, Atlanta, GA.
4. Barrett, J. C., Lamb, P. W., Wang, T. C., and Lee, T. C. (1989). Mechanisms of arsenic-induced cell transformation. Biol. Trace Elem. Res. 21, 421-429.
5. Brown, J. L., Kitchin, K.T., and George, M. (1997). Dimethylarsinic acid treatment alters six different rat biochemical parameters: Relevance to arsenic carcinogenesis. Teratog. Carcinog. Mutagen. 17, 71-84.
6. Chan, P., and Huff, J. E. (1997). Arsenic carcinogenesis in animals and in humans: Mechanistic, experimental, and epidemiological evidence. Environ. Carcino. Ecotox. Revs. C15, 83-122.
7. Cohen, S. M., Arnold, L. L., John, M. K. St., Cano, M., and van Gemert, M. Effects of dimethylarsenic acid (DMA) on urinary parameters and bladder epithelium in female F344 rats: Abstract #1086. March 1999 Society of Toxicology Annual Meeting. New Orleans, LA.
8. Farber, E. (1995). Cell proliferation as a major risk factor for cancer: A concept of doubtful validity. Cancer Res. 55, 3759-3762.
9. Germolec, D. R., Spalding, J., Boorman, G. A., Wilmer, J. L., Yoshida, T., Simeonova, P. P., Bruccoleri, A., Kayama, F., Gaido, K., Tennant, R., Burleson, F., Dong, W., Lang, R. W., and Luster, M. I. (1997). Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factors. Mutat. Res. 386, 209-218.
10. Germolec, D. R., Spalding, J., Yu, H. S., Chen, G. S., Simeonova, P. P., Humble, M. C., Bruccoleri, A., Boorman, G. A., Foley, J. F., Yoshida, T., and Luster, M. I. (1998). Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors. Am. J. Pathol 153, 1775-1785.
11. Goering, P. L., Aposhian, H. V., Mass, M. J., Cebrian, M., Beck, B. D., and Waalkes, M. P. (1999). The enigma of arsenic carcinogenesis: Role of metabolism. Toxicol. Sci. 49, 5-14.
12. Huang, S. Y., Chang, C. S., Tang, J. L., Tien, H. F., Kuo, T. L., Huang, S. F., Yao, Y. T., Chou, W. C., Chung, C. Y., Wang, C. H., Shen, M. C., and Chen, Y. C. (1998). Acute and chronic arsenic poisoning associated with treatment of acute promyelocytic leukaemia. Br. J. Haematol. 103, 1092-1095.
13. Huff, J. (1992). Chemical toxicity and chemical carcinogenesis. Is there a causal connection? A comparative morphological evaluation of 1500 experiments. IARC Sci. Publ. 116, 437-475.
14. Huff, J. E. (1994). Chemicals causally associated with cancers in humans and in laboratory animals: A perfect concordance. In Carcinogenesis. (M. P. Waalkes and J. M. Ward, Eds.), pp. 25-37. Raven Press. New York.
15. Huff, J. (1995). Mechanisms, chemical carcinogenesis, and risk assessment: Cell proliferation and cancer. Am. J. Ind. Med. 27, 293-300.
16. Huff, J. E. (1998). Carcinogenesis results in animals predict cancer risks to humans. In Maxcy-Rosenau-Last's Public Health & Preventive Medicine, 14th ed. (R. B. Wallace, Ed.), pp. 543-550, 567-569. Appleton & Lange, Norwalk, CT.
17. Huff, J. (1999a). Value, validity, and historical development of carcinogenesis studies for predicting and confirming carcinogenic risks to humans. In Carcinogenicity Testing, Predicting, & Interpreting Chemical Effects (K. T. Kitchin, Ed.), pp. 21-123. Marcel Dekker, New York.
18. Huff, J. (1999b). Chemicals associated with tumours of the kidney, urinary bladder, and thyroid glands from 2000 NTP long-term chemical carcinogenesis experiments in laboratory rodents. In Species Differences in Thyroid, Kidney and Urinary Bladder Carcinogenesis.( C. Capen, E. Dybing, J. Rice, and J. Wilbourn, Eds.), pp. 211-225. International Agency for Research on Cancer, Lyon.
19. Huff, J., Chan, P., and Waalkes, M. (1998a). Arsenic carcinogenicity testing. Environ. Health Perspect. 106, A170.
20. Huff, J. E., Haseman, J. K., DeMarini, D. M., Eustis, S., Maronpot, R. R., Peters, A. C., Persing, R. L., Chrisp, C. E., and Jacobs, A. C. (1989). Multiple-site carcinogenicity of benzene in Fischer 344 rats and B6C3F1 mice. Environ. Health Perspect. 82, 125-163.
21. Huff, J., Haseman, J., and Rall, D. (1991). Scientific concepts, value, and significance of chemical carcinogenesis studies. Annu. Rev. Pharmacol. Toxicol. 31, 621-652.
22. Huff, J. E., and Rall, D. P. (1992). Relevance to humans of carcinogenesis results from laboratory animal toxicology studies. In Maxcy-Rosenau-Last's Public Health & Preventive Medicine, 13th ed. (J. M. Last and R. B. Wallace, Eds.), pp. 433-440, 453-457. Appleton & Lange, Norwalk, CT.
23. Huff, J., Waalkes, M., and Chan, P. (1998b). Arsenic-Evidence of carcinogenicity in animals. Environ. Health Perspect. 106, A582-A583.
24. Huff, J., Waalkes, M., Nyska, A., and Chan, P. (1999). Re: apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations. J. Natl. Cancer Inst. 91, 1690-1691.
25. Hutchinson, J. (1987). Arsenic and cancer. Br. Med. J. 2, 1280-1281.
26. Hutchinson, J. (1988). Diseases, Etc., of the Skin: I. On some examples of arsenic-keratosis of the skin and of arsenic-cancer. Trans. Pathol. Soc. London. 39, 352-363.
27. IARC (1980). Arsenic and arsenic compounds. Some Metals and Metallic Compounds. In IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 23, 39-141. International Agency for Research on Cancer, Lyon, France.
28. IARC (1987). Arsenic. In Overall Evaluations of Carcinogenicity. An Updating of IARC Monographs 1 to 42. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Suppl. 7, 100-106. International Agency for Research on Cancer, Lyon, France.
29. Johansen, M. G., McGowan, J. P., Tu, S. H., and Shirachi, D. Y. (1984) Tumorigenic effect of dimethyl-arsinic acid in the rat. Proc. West. Pharmacol. Soc. 27, 289-291.
30. Lee, T. C., Oshimura, M., and Barren, J. C. (1985). Comparison of arsenic-induced cell transformation, cytotoxicity, mutation, and cytogenetic effects in Syrian hamster embryo cells in culture. Carcinogenesis 6, 1421-1426.
31. Lee, T. C., Tanaka, N., Lamb, P. W., Gilmer, T. M., and Barren, J. C. (1988). Induction of gene amplification by arsenic. Science 241, 79-81.
32. Li, W., Wanibuchi, H., Salim, E. I., Yamamoto, S., Yoshida, K., Endo, G., and Fukushima, S. (1998). Promotion of NCI-Black-Reiter male rat bladder carcinogenesis by dimethylarsinic acid an organic arsenic compound. Cancer Lett. 134, 29-36.
33. Maltoni, C., Ciliberti, A., Cotti, G., Conti, B., and Belpoggi, F. (1989). Benzene, an experimental, multipotential carcinogen: Results of the long-term bioassays performed at the Bologna Institute of Oncology. Environ. Health Perspect. 82, 109-124.
34. Ng, J. C., Seawright, A. A., Qi, L., Garnett, C. M., Moore, M. R., and Chiswell, B. (1998). Tumours in mice induced by chronic exposure of high arsenic concentration in drinking water: Abstract. Third International Conference on Arsenic Exposure and Health Effects. San Diego, CA, USA. July 1998.
35. NTP (1994). Minutes of the National Toxicology Program's Interagency Committee for Chemical Evaluation and Coordination (ICCEC) Meeting on 1 June 1999.
36. NTP (1999). Minutes of the National Toxicology Program's Interagency Committee for Chemical Evaluation and Coordination (ICCEC) Meeting on 14 December 1994.
37. NTP (2000). Arsenic and certain arsenic compounds. In Reports on Carcinogens, First and Subsequent 2nd-9th (1980-2000), pp. 17-19. National Toxicology Program, Research Triangle Park, NC.
38. Stayner, L. T., Danoivic, D. A., and Lemen, R. A. (1997). Asbestos-related cancer and the amphibole hypothesis. Amer. J. Pub. Health 87, 691.
39. Tomatis, L., Aitio, A., Wilbourn, J., and Shuker, L. (1989). Human carcinogens so far identified. Jpn. J. Cancer Res. 80, 795-807.
40. Tomatis, L, Huff, J., Hertz-Picciotto, I., Sandler, D. P., Bucher, J., Boffetta, P., Axelson, O., Blair, A., Taylor, J., Stayner, L., and Barrett, J. C. (1997). Avoided and avoidable risks of cancer. Carcinogenesis 18, 97-105.
41. Vahter, M. (1994). Species differences in the metabolism of arsenic compounds. Appl. Organometal. Chem. 8, 175-182.
42. van Gemert, M., and Eldan, M. (1998). Chronic carcinogenicity assessment of cacodylic acid: Abstract, p. 113. Third International Conference on Arsenic Exposure and Health Effects, July 1998, San Diego, CA.
43. Wanibuchi, H., Wei, M., Yamamoto, S., Li, W., and Fukushima, S. (1999). Carcinogenicity of an organic arsenical, dimethyl-arsinic acid and related arsenicals in rat urinary bladder. Proc. AACR 40, 349.
44. Wanibuchi, H., Yamamoto, S., Chen, H., Yoshida, K., Endo, G., Hori ,T., and Fukushima, S. (1996). Promoting effects of dimethylarsinic acid on N-butyl-N-(4-hydroxybutyl)nitrosamine induced urinary bladder carcinogenesis in rats. Carcinogenesis 17, 2435-2439.
45. Wei, M., Wanibuchi, H., Yamamoto, S., Li, W., and Fukushima, S. (1999). Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats. Carcinogenesis 20, 1873-1876.
46. Weinstein, I. B. (1991). Mitogenesis is only one factor in carcinogenesis. Science 251, 387-388.
47. Weinstein, I. B. (1992). Toxicity, cell proliferation, and carcinogenesis. Mol. Carcinog. 5, 2-3.
48. Wilbourn, J., Haroun, L., Heseltine, E., Kaldor, J., Partensky, C., and Vainio, H. (1986). Response of experimental animals to human carcinogens: An analysis based upon the IARC Monographs Programme. Carcinogenesis 7, 1853-1863.
49. Yamamoto, S., Konishi, Y., Matsuda, T., Murai, T., Shibata, M. A., Matsui-Yuasa, I., Otani, S., Kuroda, K., Endo, G., and Fukushima, S. (1995). Cancer induction by an organic arsenic compound, dimethylarsinic acid (cacodylic acid), in F344/DuCrj rats after pretreatment with five carcinogens. Cancer Res. 55, 1271-1276.
50. Yamamoto, S., Wanibuchi, H., Hori, T., Yano, Y., Matsui-Yuasa, I., Otani, S., Chen, H., Yoshida, K., Kuroda, K., Endo, G., and Fukushima, S. (1997). Possible carcinogenic potential of dimethylarsinic acid as assessed in rat in vivo models: a review. Mutat. Res. 386, 353-361.
51. Yamanaka, K, Hasegawa, A., Sawamura, R., and Okada, S. (1989). Dimethylated arsenics induce DNA strand breaks in lung via the production of active oxygen in mice. Biochem. Biophys. Res. Commun. 165, 43-50.
52. Yamanaka, K., Ohtsubo, K., Hasegawa, A., Hayashi, H., Ohji, H., Kanisawa, M., and Okada, S. (1996). Exposure to dimethylarsinic acid, a main metabolite of inorganic arsenics, strongly promotes tumorigenesis initiated by 4-nitroquinoline 1-oxide in the lungs of mice. Carcinogenesis 17, 767-770.
53. Yamanaka, K., Hayashi, H., Tachikawa, M., Kato, K., Hasegawa, A., Oku, N., and Okada, S. (1997). Metabolic methylation is a possible genotoxicity-enhancing process of inorganic arsenics. Mutat. Res. 394, 95-101.
54. Zhu, X. H., Shen, Y. L., Jing, Y. K., Cai, X., Jia, P. M., Huang, Y., Tang, W., Shi, G. Y., Sun, Y. P., Dai, J., Wang, Z. Y., Chen, S. J., Zhang, T. D., Waxman, S., Chen, Z., and Chen, G. Q. (1999). Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations. J. Natl. Cancer Inst. 91, 772-778.